The Department of Pharmaceuticals (DoP) has clarified that they extended the application period for the most recent PLI scheme round for bulk drugs, from June 14 to July 4, 2025...
Johnson & Johnson reported positive results from a Phase 2 study of the combination of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv)—both bispecific antibodies that have been...
Eli Lilly announced its acquisition of gene-editing startup Verve Therapeutics in a deal with up to a potential of $1.3 billion, expanding its pipeline, which now also features weight-loss medications and its blockbuster diabetes drugs...
The launch of Samsung Organoids, which is a advanced drug screening services to support clients in drug discovery and development was announced by Samsung Biologics, a leading contract development and manufacturing organization
.jpeg "India Supplies 70% of WHO Vaccines, 14% of US Generic Imports")
The Smt. Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, provided a note to address at the Second Policymakers’ Forum, organized by the Indian Pharmacopoeia Commission
.jpeg "Roche's Prasinezumab Heads to Phase III for Early-Stage Parkinson's")
Roche has reported it will move prsazinezumab, its investigational anti-alpha-synuclein antibody, into Phase III development for early-stage Parkinson’s disease following an assessment
The Forum for Quality Pharma Leaders (FQPL), will hold its national meeting on June 21 at the JSS College of Pharmacy at JSS Academy of Higher Education and Research (JSSAHER)...
Pharmaceutical company Lupin Ltd announced that it has entered into a licensing and supply agreement with China's Sino Universal Pharmaceuticals (SUP) for marketing Tiotropium dry...
In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science
Under its BioE3 (Biotechnology for Economy, Environment, and Employment) policy, which aims to promote high-performance biomanufacturing, the Department of Biotechnology (DBT) intends to support the biomanufacturing of active pharmaceutical
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
